Naloxone Hcl
Rank #434 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$19.0M
Total Cost
232,875
Total Claims
$19.0M
Total Cost
5,755
Prescribers
$82
Cost per Claim
196,514
Beneficiaries
237,685
30-Day Fills
$3,300
Avg Cost/Provider
40
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$19.0M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $19.0M total
Top Prescribers of Naloxone Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Wendy Braund | Preventive Medicine | Harrisburg, PA | 5,273 | $472K |
| 2 | Cedric Davis | Family Practice | Lauderdale Lakes, FL | 5,633 | $455K |
| 3 | Tao Sheng Kwan-Gett | Pediatric Medicine | Seattle, WA | 4,027 | $367K |
| 4 | Kathleen Toomey | Preventive Medicine | Atlanta, GA | 4,104 | $350K |
| 5 | Denise Johnson | Obstetrics & Gynecology | Meadville, PA | 2,248 | $201K |
| 6 | Eric France | Pediatric Medicine | Denver, CO | 1,849 | $152K |
| 7 | James Hussey | Psychiatry & Neurology | Mandeville, LA | 1,446 | $123K |
| 8 | Timothy Jones | Family Practice | Nashville, TN | 1,338 | $107K |
| 9 | Jinlene Chan | Pediatric Medicine | Annapolis, MD | 1,170 | $98K |
| 10 | Martin Duclos | Internal Medicine | Conway, SC | 875 | $94K |
| 11 | Nikan Khatibi | Anesthesiology | Corona, CA | 1,047 | $84K |
| 12 | Jason Mcelyea | Emergency Medicine | Mcalester, OK | 1,099 | $83K |
| 13 | Richard Clark | Family Practice | Marietta, OH | 1,024 | $78K |
| 14 | Laura Herrera | Internal Medicine | Baltimore, MD | 850 | $75K |
| 15 | David Adinaro | Emergency Medicine | Paterson, NJ | 795 | $71K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 431 | Tasimelteon (Hetlioz) | $19.3M | 763 |
| 432 | Isavuconazonium Sulfate (Cresemba) | $19.2M | 3,050 |
| 433 | Paroxetine Hcl (Paroxetine Hcl) | $19.2M | 1,226,222 |
| 434 | Naloxone Hcl (Naloxone Hcl) | $19.0M | 232,875 |
| 435 | Elapegademase-Lvlr (Revcovi) | $19.0M | 52 |
| 436 | Methylprednisolone (Methylprednisolone) | $18.9M | 1,934,494 |
| 437 | Sacrosidase (Sucraid) | $18.5M | 1,517 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology